Literature DB >> 24681951

Decreased TIP30 promotes Snail-mediated epithelial-mesenchymal transition and tumor-initiating properties in hepatocellular carcinoma.

M Zhu1, F Yin2, X Fan3, W Jing4, R Chen3, L Liu4, L Zhang3, Y Liu3, Y Liang3, F Bu3, X Tong3, H Zheng4, J Zhao2, Y Guo2.   

Abstract

The poor prognosis of hepatocellular carcinoma (HCC) is mainly due to tumor recurrence and metastases. Recently, epithelial-mesenchymal transition (EMT) has been implicated in tumor invasion and metastasis. However, the underlying molecular mechanisms are yet to be elucidated. Here, we show that 30-kDa Tat-interacting protein (TIP30), also called CC3, is significantly downregulated during transforming growth factor-β-induced EMT. In our in vitro and in vivo studies, we show that decreased TIP30 expression leads to EMT, as well as enhanced motility and invasion of HCC cells. Also, increased self-renewal ability and chemotherapeutic resistance are observed with TIP30 depletion. Moreover, Snail is one of the key transcription factors promoting EMT, and overexpression of TIP30 greatly decreased nucleic accumulation in Snail through the regulation of intracellular localization. Small interfering RNAs targeting Snail attenuated EMT and tumor-initiating properties induced by TIP30 deficiency. We further confirmed that TIP30 competitively interrupted the interaction of Snail with importin-β2 to block the nuclear import of Snail. Consistently, TIP30 expression significantly correlates with E-cadherin expression in HCC patients. TIP30 or combination of E-cadherin is a powerful marker in predicting the prognosis of HCC. Taken together, our results suggest a novel and critical role of TIP30 involved in HCC progression and aggressiveness.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24681951     DOI: 10.1038/onc.2014.73

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma.

Authors:  Fangfang Bu; Xing Liu; Jingjing Li; Shukun Chen; Xin Tong; Chunsheng Ma; Hui Mao; Fei Pan; Xiaoyan Li; Bo Chen; Liyan Xu; Enmin Li; Geng Kou; Jun Han; Shangjing Guo; Jian Zhao; Yajun Guo
Journal:  Oncotarget       Date:  2015-02-10

Review 2.  Osteopontin-A Master Regulator of Epithelial-Mesenchymal Transition.

Authors:  Anai N Kothari; Matthew L Arffa; Victor Chang; Robert H Blackwell; Wing-Kin Syn; Jiwang Zhang; Zhiyong Mi; Paul C Kuo
Journal:  J Clin Med       Date:  2016-03-23       Impact factor: 4.241

3.  MiR-25 promotes hepatocellular carcinoma cell growth, migration and invasion by inhibiting RhoGDI1.

Authors:  Congren Wang; Xuejin Wang; Zijian Su; Hongjiang Fei; Xiaoyu Liu; Qunxiong Pan
Journal:  Oncotarget       Date:  2015-11-03

4.  Oncogenic potential of histone-variant H2A.Z.1 and its regulatory role in cell cycle and epithelial-mesenchymal transition in liver cancer.

Authors:  Hee Doo Yang; Pum-Joon Kim; Jung Woo Eun; Qingyu Shen; Hyung Seok Kim; Woo Chan Shin; Young Min Ahn; Won Sang Park; Jung Young Lee; Suk Woo Nam
Journal:  Oncotarget       Date:  2016-03-08

5.  Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection.

Authors:  Xia Zhang; Lizhi Lv; Xuenong Ouyang; Shi'an Zhang; Jian Fang; Lirong Cai; Dongliang Li
Journal:  Cancer Med       Date:  2016-07-15       Impact factor: 4.452

6.  Tat-Interacting Protein 30 (TIP30) Expression Serves as a New Biomarker for Tumor Prognosis: A Systematic Review and Meta-Analysis.

Authors:  Tao Xu; Zhichao Jin; Yuan Yuan; Honggang Zheng; Conghuang Li; Wei Hou; Qiujun Guo; Baojin Hua
Journal:  PLoS One       Date:  2016-12-30       Impact factor: 3.240

Review 7.  New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.

Authors:  Anushka Dongre; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2019-02       Impact factor: 94.444

Review 8.  Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma.

Authors:  Zhi Zeng; Qiliang Lu; Yang Liu; Junjun Zhao; Qian Zhang; Linjun Hu; Zhan Shi; Yifeng Tu; Zunqiang Xiao; Qiuran Xu; Dongsheng Huang
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

9.  Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.

Authors:  Abin You; Manqing Cao; Zhigui Guo; Bingfeng Zuo; Junrong Gao; Hongyuan Zhou; Huikai Li; Yunlong Cui; Feng Fang; Wei Zhang; Tianqiang Song; Qiang Li; Xiaolin Zhu; Haifang Yin; Huichuan Sun; Ti Zhang
Journal:  J Hematol Oncol       Date:  2016-03-08       Impact factor: 17.388

10.  Reduction of Tat-interacting Protein 30 Expression Could be a Prognostic Marker in Bladder Urothelial Cancer.

Authors:  Ye-Ping Li; Jian-Fang Zhu; Ka-Te Huang; Rong-Rong Wang; Bing Cai; Hui Xie; Hong-De Chen
Journal:  Chin Med J (Engl)       Date:  2018-01-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.